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Genetic makeup of the host plays a significant role in the course and outcome of infection. Inbred strains of mice
display a wide range of sensitivities to Listeria monocytogenes infection and thus serve as a good model for analysis of
the effect of genetic polymorphism. The outcome of L. monocytogenes infection in mice is influenced by the ability of
this bacterium to induce expression of interferon beta mRNA, encoded in mouse by the Ifnb1 (interferon beta 1,
fibroblast) gene. Mouse strains that lack components of the IFNb signaling pathway are substantially more resistant to
infection. We found that macrophages from the ByJ substrain of the common C57BL/6 inbred strain of mice are
impaired in their ability to induce Ifnb1 expression in response to bacterial and viral infections. We mapped the locus
that controls differential expression of Ifnb1 to a region on Chromosome 7 that includes interferon regulatory factor 3
(Irf3), which encodes a transcription factor responsible for early induction of Ifnb1 expression. In C57BL/6ByJ mice, Irf3
mRNA was inefficiently spliced, with a significant proportion of the transcripts retaining intron 5. Analysis of the Irf3
locus identified a single base-pair polymorphism and revealed that intron 5 of Irf3 is spliced by the atypical U12-type
spliceosome. We found that the polymorphism disrupts a U12-type branchpoint and has a profound effect on the
efficiency of splicing of Irf3. We demonstrate that a naturally occurring change in the splicing control element has a
dramatic effect on the resistance to L. monocytogenes infection. Thus, the C57BL/6ByJ mouse strain serves as an
example of how a mammalian host can counter bacterial virulence strategies by introducing subtle alteration of
noncoding sequences.
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Introduction
Bacterial pathogens utilize a wide range of approaches to
down-modulate or subvert host immune responses. L.
monocytogenes is an intracellular pathogen that, following
invasion of the host cell, is capable of escaping the host
phagolysosomes and replicating in the cytoplasm. Within the
cytoplasm, the bacterial DNA is thought to be recognized by
an unknown host receptor, activating a signaling cascade that
rapidly induces Ifnb1 expression [1]. This signaling cascade
relies on TANK-binding kinase 1 (TBK1)-mediated phosphor-
ylation of IRF3, a transcription factor that, following
dimerization and translocation to the nucleus, induces
expression of Ifnb1 [2–4].
In a murine model of infection, activation of host IFNb
signaling is an important L. monocytogenes virulence strategy.
Mouse lines that lack components of the IFNb signaling
pathway (Ifnb1, Ifnar1) are signiﬁcantly more resistant to L.
monocytogenes infection [2,4–6]. A similar protective effect of a
Irf3 knockout suggests that Toll-like receptor (TLR)–inde-
pendent induction of IFNb is detrimental to control of
listeriosis [7]. Several independent observations suggested
that IFNb signaling sensitizes lymphocytes for cell death,
leading to an increase in sensitivity to L. monocytogenes [8]. L.
monocytogenes activates such proapoptotic genes as Trail
(Tnfsf10), Pkr (Eif2ak2), and Daxx in spleen and bone marrow
macrophages of wild-type, but not Ifnar-deﬁcient mice [4].
This is consistent with the observation that Trail knockout
mice are more resistant to L. monocytogenes infection [9]. It has
also been noted that following infection, mice lacking
components of the IFNb signaling machinery have higher
total numbers of macrophages. This could be due to the
ability of Type I interferon signaling to accelerate cell death
of L. monocytogenes–infected macrophages [3].
Inbred mouse strains are extensively used as a model
system to study host immune response throughout the course
of L. monocytogenes infection. In addition, common strains
display a wide range of sensitivities to intravenous infection
with L. monocytogenes [10]. Our initial analysis of genetic
determinants affecting susceptibility to L. monocytogenes
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susceptible inbred mouse strains: BALB/cByJ and C57BL/
6ByJ [11]. These strains were selected based on the ancestry of
the 13-member CXB Recombinant Inbred (RI) Panel, which
serves as a useful tool for mapping single gene traits [12].
While our study identiﬁed two major genetic loci that
controlled differential sensitivity to L. monocytogenes infection,
it was clear that there were additional genetic factors that we
did not detect due to the limited size of our cross. Here, we
report identiﬁcation and characterization of one of these
additional factors, a polymorphism in the C57BL/6ByJ inbred
mouse strain that affects expression of Ifnb1 and results in
increased resistance to L. monocytogenes infection. Our data
demonstrate that a single base-pair polymorphism in intron 5
of Irf3 reveals an important role for splicing in control of
IFNb induction and innate immune function.
Results
C57BL/6ByJ Strain-Specific Defect in Induction of Ifnb1
Expression
Our analysis of L. monocytogenes infection of macrophages
derived from bone marrow (i.e., bone marrow macrophages;
BMMs) of BALB/cByJ and C57BL/6ByJ strains revealed strain-
speciﬁc differences in infection-induced cell death. Across a
range of time points and infectious doses, BALB/cByJ BMMs
had consistently higher cell death then BMMs from C57BL/
6ByJ mice (Figure 1A and 1B). Interestingly, 18 h following
infection with L. monocytogenes, there were also signiﬁcant (p ,
0.001) differences in death of BMMs from J and ByJ substrains
of the common C57BL/6 lineage (Figure 1C). The observed
differences in cell death could be due to small differences in
replication of bacteria in infected BMMs (Figure 1D).
However, recent studies that have demonstrated a role for
IFNb signaling in the outcome of L. monocytogenes infection
have also suggested that it plays a role in the survival of
macrophages [2]. Therefore, we chose to test if there are
mouse strain-speciﬁc differences in IFNb signaling, and we
analyzed the course of Ifnb1 mRNA induction in L.
monocytogenes–infected BMMs. We found that Ifnb1 expression
was rapidly induced in BALB/cByJ BMMs, increasing 400-fold
by the 4-h time point. By contrast, in C57BL/6ByJ BMMs,
there was very slight induction of Ifnb1 mRNA, reaching only
12-fold by the 4-h time point (Figure 2A). This low level of
Ifnb1 induction in C57BL/6ByJ mice was surprising, as the role
of Ifnb1 signaling in conferring susceptibility to L. mono-
cytogenes infection has been analyzed using mice of the C57BL/
6 background [4]. To test the possibility that the defect in
Ifnb1 induction was speciﬁc to the C57BL/6ByJ substrain we
also monitored expression of Ifnb1 in BMMs from C57BL/6J
mice. Indeed, in response to L. monocytogenes infection, C57BL/
6J BMMs had a similar magnitude of Ifnb1 mRNA induction as
BALB/cByJ BMMs (Figure 2A). Ifnb1 mRNA induction in F1
progeny of the J and ByJ substrains of mice was similar to that
observed in the C57BL/6J strains (unpublished data), suggest-
ing that the C57BL/6ByJ strain carries a recessive poly-
morphism that prevents upregulation of Ifnb1 expression.
There is at least one additional inbred mouse strain, SPRET/
Ei, that has a similar naturally occurring defect in induction
of Ifnb1 expression [13]. However, the genetic basis for this
defect in SPRET/Ei remains to be elucidated.
Differential Sensitivity of C57BL/6 Substrains to L.
monocytogenes Infection
Several lines of evidence indicate that inhibition of IFNb
signaling in mice leads to a signiﬁcant increase in resistance
to intravenous L. monocytogenes infection [4,5]. To test if the
Ifnb1 induction defect in the C57BL/6ByJ strain promotes
resistance to infection, we compared survival and bacterial
loads in C57BL/6 substrains infected intravenously with a
high dose (10
5 colony-forming units [cfu]) of L. monocytogenes
strain 10403S. There was no detectable Ifnb1 expressed in
liver and spleen tissue in either mouse strain up until the 24-h
time point. At the 24-h time point, Ifnb1 mRNA was present
in both livers and spleens of C57BL/6J animals but only in
spleens of C57BL/6ByJ animals (Figure S1). We found that at
the 24- and 48-h time points, there was a signiﬁcantly higher
number of bacteria in the livers (Figure 3A) and spleens
(Figure 3B) of C57BL/6J mice, indicating the infection was
controlled better in C57BL/6ByJ mice. Consistent with this
idea, spleens from C57BL/6ByJ animals had nearly twice as
many Mac1-positive cells than spleens from C57BL/6J mice at
the 48-h time point (Figure 3C). In fact, this dose of bacteria
led to death in C57BL/6J animals within 72 h after infection,
whereas most of the C57BL6/ByJ mice survived indeﬁnitely
(Figure S2). Collectively, these results indicate that C57BL/
6ByJ mice were signiﬁcantly more resistant to intravenous L.
monocytogenes infection than C57BL/6J animals.
Ifnb1 Induction Defect Lies in a Shared Component of the
Signaling Pathway
Intracellular L. monocytogenes is thought to induce Ifnb1
expression by activating an as-of-yet unidentiﬁed cytoplasmic
receptor that initiates signaling through the TBK1 and
inhibitor of kappaB kinase epsilon (IKBKE) kinases [1].
TBK1 and IKBKE also participate in transducing signals
from various TLRs in response to viral and bacterial
infections [14]. Therefore, we tested if the defect in C57BL/
6ByJ mice was in a L. monocytogenes–speciﬁc component of the
TBK1/IKBKE signaling pathway or in a component shared
with other pathways. Treatment of C57BL/6ByJ BMMs with
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Author Summary
Specific variances in an individual’s DNA, known as genetic
polymorphisms, can play a significant role in determining suscept-
ibility to an infectious disease. To identify the genetic poly-
morphisms that are associated with resistance to the common
human bacterial pathogen L. monocytogenes, we have carried out a
series of genetic and molecular biology experiments using closely
related strains of mice that are differentially susceptible to Listeria
infection. Through this analysis, we have identified a spontaneous
mutation in an intron of the Irf3 gene, which encodes a key
transcription factor involved in innate immunity. This single
nucleotide change affects the efficiency with which Irf3 mRNA is
spliced, thus limiting the ability of bacteria to induce interferon beta
expression in order to suppress innate immune defense. By
analyzing this mutation, we found that processing of mouse Irf3
mRNA relies on an atypical U12 splicing mechanism that has been
suggested to be a rate-limiting step in gene expression. Our findings
not only provide an additional example of an important role of
noncoding polymorphisms in control of gene function, but also
demonstrate how such polymorphisms can fine tune innate
immune response.lipopolysaccharide or poly I:poly C, which induce Ifnb1
expression through TLR4 and TLR3, respectively, failed to
induce Ifnb1 mRNA at the same levels as observed in C57BL/6J
BMMs (Figure 2B and 2C). On the other hand, C57BL/6ByJ
BMMs treated with 200 hemagglutinizing units (HU) of
Sendai virus, which induces Ifnb1 expression through a RIG-
I/MAVS–dependent pathway [15], had levels of Ifnb1 mRNA
comparable to those observed in C57BL/6J BMMs at the later
stages of infection but nevertheless had a noticeable delay at
the earlier stages (Figure 2D). These observations indicate
that the defect in Ifnb1 induction in C57BL/6ByJ mice is likely
to lie in a shared component of the signaling pathway.
However, our initial analysis Tbk1, Ikbke, and Irf3 failed to
identify differences in the coding sequence or overall
expression levels of these mRNAs in C57BL/6ByJ versus
C57BL/6J mice (unpublished data).
Mapping of the Ifnb1 Induction Trait
As mentioned above, our original choice of mouse strain
for genetic analysis was based on the availability of the CXB
RI mapping panel. However, analysis of the transcriptional
response to L. monocytogenes infection in macrophages from all
13 CXB strains revealed no differences in induction of Ifnb1
(unpublished data), precluding the use of the panel for
mapping. Because C57BL/6ByJ mice carry a recessive muta-
tion, we therefore chose a backcross as our mapping strategy
to identify the locus in the C57BL/6ByJ mouse genome that
harbors the mutation preventing induction of Ifnb1. C57BL/
ByJ and C57BL/6J mice have virtually no polymorphisms that
can be used to monitor allelic segregation in a cross. On the
other hand, BALB/cByJ mice are similar to C57BL/6J mice in
their induction of Ifnb1, and we therefore chose C57BL/6ByJ
and BALB/cByJ as parental strains for our cross. We
backcrossed F1 male progeny of C57BL/6ByJ and BALB/cByJ
mice to C57BL/6ByJ females and used the resulting 54 C(B.C)
N2 progeny to construct a genetic map with 56 microsatellite
markers evenly distributed throughout the mouse genome
[16]. To generate phenotypic data, we ﬁrst used real time
reverse transcriptase PCR (RT-PCR) to analyze the dynamics
of L. monocytogenes-induced Ifnb1 expression in BMMs isolated
from 43 backcrossed mice (unpublished data). We then used
transformed real time RT-PCR Ct values representing the
levels of Ifnb1 mRNA at the 4-h time point directly as a
quantitative trait. Mapping of this trait using MapManger
QTX identiﬁed a peak likelihood ratio statistic score of 35.1
(logarithm of the odds [LOD] ¼ 7.6) at the D7Mit229 marker
[17] (Figure S3). Using the MapManger QTX built-in
permutation test function, we established that the identiﬁed
linkage is highly signiﬁcant with an experimental p-value less
Figure 1. Induction of Macrophage Cell Death by Infection with L. monocytogenes
(A) Mice were infected with L. monocytogenes (LM) at MOI5 and BMM cell death was monitored by the release of the cytosolic enzyme LDH into the
supernatant. Over the 36-h time period a greater proportion of BALB/cByJ BMMs than of C57BL/6ByJ BMMs died as a result of infection.
(B) Differences in death of C57BL6/ByJ and BALB/cByJ macrophages were maintained across varying MOIs at 18 h post infection.
(C) BMMs from C57BL/6 substrains infected for 18 h with L. monocytogenes at MOI5 had significantly different amounts of dead cells (p , 0.001).
(D) Death of BMMs exposed intracellular L. monocytogenes to gentamicin in the media, resulting in reduction of recovered bacteria after the 8-h time
point.
doi:10.1371/journal.pgen.0030152.g001
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 4. QTL support interval was approximated as 1.5
LOD drop-off from the peak score [18] and extended from
D7Mit27 to D7Mit158 markers, spanning empirical genetic
distance of 6.9 cM (0 cM MGI) and a physical fragment of 2.35
Mb. The D7Mit229 marker is located on mouse Chromosome
7a d j a c e n tt oIrf3 [16], identifying Irf3 as the primary
candidate gene.
Irf3 mRNA in C57BL/6ByJ Strain Is Not Efficiently Spliced
Interestingly, our initial analysis of C57BL/6J and C57BL/
6ByJ substrains did not ﬁnd any differences in overall Irf3
mRNA levels or polymorphisms in the coding region of Irf3
(unpublished data). However, analysis of the structure of Irf3
mRNA using a series of overlapping primers revealed
differences in the Irf3 transcripts between the two substrains.
As expected, in C57BL/6J mice the majority of Irf3 transcripts
were completely spliced, whereas in C57BL/6ByJ mice,
splicing of Irf3 was not complete and the majority of
transcripts retained intron 5 (Figure 4A and quantiﬁed in
Figure 4B). Retention of intron 5 introduces a premature
stop codon at amino acid 243, rather than producing the full-
length 419 amino-acid protein. To test if the observed
differences in splicing had functional signiﬁcance, we
analyzed activation of IRF3 in BMMs by monitoring the
formation of IRF3 dimers following bacterial (L. monocytogenes)
or viral (Sendai virus) infection. We found that untreated
BMMs from C57BL/6ByJ mice had signiﬁcantly lower levels of
IRF3 protein than untreated BMMs from C57BL/6J mice
(Figure 4C and 4D). Moreover, following a 2-h infection with
L. monocytogenes or Sendai virus, there were no detectable IRF3
dimers in C57BL/6ByJ BMMs, although IRF3 dimers were
readily detectable in C57BL/6J BMMs. Nevertheless, we
observed that Sendai virus–infected C57BL/6ByJ BMMs are
capable of inducing Ifnb1 expression (see Figure 2D). This is
consistent with earlier observations that Irf3-deﬁcient cells
rely on IRF7 to have a normal interferon response to several
viral infections [19,20]. Interestingly, our polyclonal anti-
bodies failed to detect a truncated form of IRF3 even in the
presence of proteasome inhibitor (MG132), suggesting that
the unspliced form of Irf3 might not be efﬁciently translated
(Figure 4C). Overall, these results show that C57BL/6ByJ
BMMs have dramatically lower amounts of functional IRF3
protein, and in conjunction with the existing Irf3 knock-out
data [2,4], explain the increased resistance of C57BL/6ByJ
mice to L. monocytogenes infection (see Figure 3).
Figure 2. Mouse Strain-Specific Differences in Induction of Ifnb1 mRNA Measured by Real Time RT-PCR
(A) In response to L. monocytogenes infection, C57BL/6ByJ BMMs show nearly 100-fold lower induction of Ifnb1 mRNA compared to BMMs from BALB/
cByJ and C57BL/6J strains.
(B, C) Treatment of BMMs with 25 lg/ml poly I:poly C (B) or 1 lg/ml lipopolysaccharide (C) fails to appreciably induce Ifnb1 mRNA in C57BL/6ByJ mice.
(D) Incubation of BMM with 200 HU of Sendai Virus demonstrates delayed kinetics of Ifnb1 induction in C57BL/6ByJ mice. All figures are representatives
of at least three independent experiments (6STD, n¼4). Ifnb1 mRNA induction is measured relative to the uninduced Ifnb1 mRNA levels in C57BL/6J
BMMs.
doi:10.1371/journal.pgen.0030152.g002
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C57BL/6ByJ Strain
Sequencing of the entire 7.2-kb genomic region of Irf3 [21],
including 1 kb of upstream and downstream sequences,
revealed a single A to T polymorphism in the middle of
intron 5 in C57BL/6ByJ mice (Figure 5). To establish if this
polymorphism altered the splicing efﬁciency of the intron, we
monitored splicing using both cell culture–based and in vitro
approaches. For cell culture–based experiments, we derived
minigene constructs containing the complete intron 5 (from
either C57BL/6J or C57Bl/6ByJ) ﬂanked by exons 5 and 6, and
expressed them under the control of the heterologous CMV
promoter. In order to rule out the possibility that C57BL/6ByJ
mice carry additional mutations that affect splicing, we ﬁrst
tested our constructs in a C57BL/6ByJ ﬁbroblast-like cell line
(Y5). Following transfection into Y5 cells, the efﬁciency of
splicing of intron 5 was monitored by real time RT-PCR using
primers speciﬁc to the vector and exon 5–6 junctions, and the
total amount of RNA expressed from each construct was
measured using primers speciﬁc to the exon fragment, which
is identical in both constructs (see Figure 6A schematic).
When normalized for the total amount of expressed RNA,
there was signiﬁcantly more spliced product generated from
the C57BL/6J construct than from the C57BL/6ByJ construct
(Figure 6A). This result indicates that in C57BL/6ByJ cells,
C57BL/6J Irf3 intron 5 is spliced more efﬁciently than the
C57BL/6ByJ version of the intron.
The effect of the A to T substitution on splicing efﬁciency
of intron 5 was further conﬁrmed using an in vitro splicing
assay, in which a uniformly radioactively labeled Irf3 pre-
mRNA containing intron 5 ﬂanked by 50 bp of exon 5 and
exon 6 was incubated in HeLa nuclear extract. As expected,
the C57BL/6J-derived Irf3 pre-mRNA substrate was spliced
efﬁciently, as evidenced by the appearance of both inter-
mediate and fully spliced products (Figure 6B). By contrast,
there was no detectable splicing of the C57BL/6ByJ-derived
Irf3 pre-mRNA substrate even when incubated for 60 min in
the splicing reaction mixture. These results conﬁrmed that
the A to T substitution had a direct effect on efﬁciency of Irf3
splicing.
Splicing of Murine Irf3 Intron 5 Relies on U12 Splicesome
Pre-mRNA splicing occurs in a ribonucleoprotein complex
called the spliceosome [22]. Splicing is initiated through
recognition of several intron-deﬁning splicing signals, in-
cluding the 59 and 39 splice sites and the branchpoint, which
is usually located near the 39 end of the intron. Introns can be
classiﬁed into two categories: U2-type introns, which com-
prise the major class of introns, and U12-type introns. U2-
type introns are characterized by the presence of a conserved
Figure 3. Differences in Susceptibility to L. monocytogenes Infection of C57BL/6 Substrains
(A, B) C57BL/6J mice have significantly elevated bacterial loads in their livers (A) and spleens (B) at all time points following intravenous infection with
10
5 cfu L. monocytogenes. At the 96-h time point following infection all C57BL/6J mice were dead.
(C) C57BL/6ByJ mice have twice as many Mac-1 positive cells in their spleens than C57BL/6J mice at the 48-h time point post infection.
doi:10.1371/journal.pgen.0030152.g003
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AG dinucleotide at the 39 end, whereas U12-type introns can
harbor AT–AC, AT–AG, and GU–AG dinucleotides at their 59
and 39 boundaries, respectively. Furthermore, on U12-type
introns, the 59 and 39 splice sites and branchpoint are highly
conserved and differ from those of the conventional U2-type
introns [23,24], and the characteristic polypyrimidine tract is
typically absent [25].
Because the A to T polymorphism is located within an
intron and affects splicing efﬁciency, we hypothesized that it
might alter the function of a splicing signal. The poly-
morphism is located 46 bp upstream of the 39 splice site,
within a region where the branchpoint is typically found. The
59 boundary of the murine Irf3 intron 5 matches the U2-type
intron GTRAGT consensus sequence (Figure 5) [23,24].
However, the region surrounding the polymorphism more
closely resembled the U12 branchpoint consensus (TCCTTA-
ACY) than the U2 branchpoint consensus (YURAY). To
determine whether intron 5 of the Irf3 gene was a U2-type or
U12-type intron, we monitored splicing of the wild-type
C57BL/6J-derived Irf3 pre-mRNA substrate following inacti-
vation of U2 or U12 snRNA by oligonucleotide-directed
Figure 4. Mouse Strain-Specific Differences in Irf3 mRNA and Protein Levels
(A) The majority of C57BL/6ByJ BMM Irf3 transcripts retain intron 5 (upper band), whereas in both C57BL/6J and BALB/cByJ strains most of Irf3 pre-
mRNA is properly spliced.
(B) In C57BL/6J BMMs, there is on average 4-fold more (p , 0.0001) fully spliced and 2-fold less (p , 0.01) unspliced Irf3 transcripts than in C57BL/6ByJ
BMMs. Amounts of Irf3 mRNA were measured relative to a C57BL/6ByJ sample using primer pairs specific to denoted areas of the Irf3 mRNA (6STD, n¼
6).
(C) Inefficient splicing of Irf3 results in decreased levels of IRF3 protein in unstimulated (T0) and L. monocytogenes-infected (T4) C57BL/6ByJ
macrophages. The truncated version of IRF3 predicted to be produced by translation of unspliced Irf3 mRNA was not detected even in the presence of
the proteosomal inhibitor MG132.
(D) Two-hour infection of C57BL/6J BMMs with either L. monocytogenes (LM) or Sendai Virus (SeV) leads to formation of the transcriptionally active IRF3
dimer, whereas infection of C57BL/6ByJ cells produces virtually undetectable amounts of IRF3 dimer. Total amount of loaded protein was monitored by
immunoblotting with an anti-actin antibody.
doi:10.1371/journal.pgen.0030152.g004
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shows that splicing of the C57BL/6J-derived Irf3 pre-mRNA
substrate occurred following inactivation of U2 snRNA but
not following inactivation of U12 snRNA. As expected,
splicing of the control U2-type intron–containing adenovirus
major late (Ad ML) pre-mRNA substrate was fully dependent
on the presence of U2 snRNA. These observations indicate
that splicing of intron 5 of the Irf3 gene relies on the U12-
dependent mechanism.
Irf3 Intron 5 A to T Polymorphism Affects Induction of
Ifnb1 Expression
Irf3 transcripts that retain intron 5 are detected in both
C57BL/6ByJ and C57BL/6J strains (see Figure 4A). Therefore,
it appears that even in the C57BL/6J strain splicing of intron
5 is somewhat inefﬁcient, whereas in the C57BL/6ByJ strain,
intron 5 splicing is substantially impaired. To test if the
observed phenotypic differences in induction of Ifnb1
expression in the two mouse strains are due to differences
in splicing efﬁciency of Irf3 intron 5, we performed
complementation experiments. To achieve this, we trans-
fected BMMs from Irf3 knockout mice with full-length in vitro
transcribed Irf3 mRNA species harboring either the C57BL/6J
or C57BL/6ByJ version of intron 5. Fully spliced Irf3 mRNA
was used as a positive control, and mRNA containing a partial
deletion of IRF domain (DXma) was used as a negative
control. Previous experiments had shown that introduction
of single-stranded RNA into the cell cytosol leads to Irf3-
dependent induction of Ifnb1 expression [26–28] (O. G.,
unpublished data). Therefore, transfection of intron 5–
containing Irf3 mRNAs into BMMs that lack Irf3 should lead
to a level of Ifnb1 induction that is proportional to the
splicing efﬁciency of intron 5. We measured the levels of Ifnb1
mRNA by real time RT-PCR 19 h following transfection of
BMMs, and found that there was ;5-fold more (p , 0.01) Ifnb1
mRNA expressed in BMMs transfected with the C57BL/6J-
derived Irf3 mRNA than in BMMs transfected with C57BL/
6ByJ-derived Irf3 mRNA (Figure 7). Following a 4-h infection
with L. monocytogenes, BMMs transfected with either mRNA
showed further induction of Ifnb1 expression. Nevertheless,
the C57BL/6J-derived Irf3 mRNA induced signiﬁcantly (p ,
0.01) higher amounts of Ifnb1 mRNA than the C57BL/6ByJ-
derived version. As expected, BMMs transfected with Irf3
mRNA lacking the IRF domain induced only low levels of
Ifnb1 mRNA expression. Because the Irf3 knockout mice used
in this experiment are on the C57BL/6J background [19], this
experiment also ruled out the possibility that impaired
splicing of Irf3 intron 5 could be due to a linked C57BL/
6ByJ polymorphism. Therefore, we conclude that decreased
splicing efﬁciency of Irf3 intron 5 is directly responsible for
the reduction in Ifnb1 expression observed in C57BL/6ByJ
mice.
Discussion
Previous studies have demonstrated an important role of
IFNb signaling in host defense against L. monocytogenes
infection. L. monocytogenes evolved to take advantage of the
host signaling pathways and is capable of inducing Ifnb1
expression in order to down-modulate the antibacterial host
defense. Here, we show that at least one inbred strain of mice
c a nr e s i s tt h i sp a t h o g e n ’ st a c t i cb yc a r r y i n gas i n g l e
nucleotide polymorphism that changes the efﬁciency of
splicing of its Irf3 transcription factor. While this naturally
occurring polymorphism does not eliminate IRF3 activity, the
resulting reduction in IRF3 protein levels is sufﬁcient to
confer 10-fold higher resistance to L. monocytogenes infection.
Considering that complete loss of IRF3 function is detrimen-
tal to immune defense, and Irf3 knockout mice are more
sensitive to encephalomyocarditis infection [19], it would be
interesting to determine if the level of IRF3 in C57BL/6ByJ
mice is sufﬁcient to maintainp r o t e c t i o na g a i n s tv i r a l
infections. Nevertheless, our ﬁnding indicates that genetic
changes in noncoding regions of the host genome is one of
the mechanisms that can be used to ﬁne tune the effective-
ness of host defenses against infections.
It has been suggested that in the process of evolution, U12-
type introns are either lost or undergo subtype switching
(from AT–AC to GT–AG) and are eventually converted to U2-
type introns [25]. Our data provide additional support for
this hypothesis. Although splicing of IRF3 intron 5 is
dependent on the U12 spliceosome, the splice donor site is
a typical U2 site. Even more interesting is the fact that the
region of the human and rhesus intron 5 that is homologous
to the putative murine U12 branchpoint site contains a G in
place of the T that is found in rodents (Figure 5, inset box).
This substitution places a purine residue in front of a
putative branchpoint adenosine, thus creating a perfect
match to the canonical U2 branchpoint consensus sequence.
Therefore, intron 5 of the murine Irf3 gene might represent
one of the ﬁnal steps in the conversion of a U12-type intron
to a U2-type intron.
The amount of IRF3 available in the cell is tightly
controlled and overproduction of IRF3 is lethal to BMMs
Figure 5. Alignment of the Intron 5 Sequences from the Irf3 Genes from Mouse (Substrains C57BL/6J and C57BL/6ByJ), Rat, Human, and Rhesus Monkey
The A to T polymorphism (arrow) observed in the Irf3 gene in C57BL/6ByJ mice is found within a conserved sequence (boxed) similar to the U12
TCCTAACY branchpoint consensus. A T to G substitution found in the human and rhesus genes converts a pyrimidine to a purine residue in front of a
putative branchpoint adenosine and creates a perfect match (inset box) to the U2 YURAY branchpoint consensus.
doi:10.1371/journal.pgen.0030152.g005
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Irf3 Splicing Controls Resistance to InfectionFigure 6. Mouse Strain-Specific Differences in Irf3 Intron 5 Splicing
(A) Relative levels of the spliced to unspliced forms of an Irf3 intron 5–containing minigene expressed in C57BL/6ByJ fibroblast-like Y5 cells 12 h
following transfection. Levels are normalized to the total amount of expressed RNA. The location of the primers used in the analysis is shown in the
schematic diagram. The efficiency of splicing of intron 5 was monitored using primers specific to the vector and exon 5–6 junctions (top pair), whereas
the total amount of RNA expressed from each construct was measured using primers specific to the exon fragment (bottom pair).
(B) In vitro splicing of the C57BL/6J of C57BL/6ByJ minigene pre-mRNA was analyzed at 0, 15, 30, and 60 min following addition of the substrate to the
nuclear extract. Identities of the spliced products are shown of the left.
(C) In vitro splicing of the C57BL/6J minigene pre-mRNA was analyzed at 0, 30, and 60 min following inactivation of U2 or U12 snRNA by oligonucleotide
directed RNase H cleavage. As a control, splicing of the U2-type intron–containing adenovirus major late (Ad ML) pre-mRNA substrate was analyzed.
doi:10.1371/journal.pgen.0030152.g006
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Irf3 Splicing Controls Resistance to Infection[29,30] (Figure S4). Recent evidence indicates that splicing of
U12-type introns could be a rate-limiting step in gene
expression [31]. Our analysis suggests that this may also be
the case for intron 5 in the murine Irf3 gene. Macrophages
from common strains, such as C57BL/6J and BALB/cByJ, have
two populations of Irf3 transcripts: a major, fully spliced
species and a minor species that retains intron 5 (see Figure
4A). The presence of multiple Genbank (i.e., BC082274,
BC003233; http://www.ncbi.nlm.nih.gov/Genbank/index.html)
and EST entries of Irf3 mRNAs that retain intron 5 further
supports this hypothesis. Therefore, the rate of intron 5
splicing could control the amount of IRF3 available in the
cell. Interestingly, it has been shown that activity of human
IRF3 is also regulated at the level of splicing [32]. However, in
contrast to rodent Irf3, regulation of human IRF3 involves
alternative intron 1 splice acceptor sites that can produce an
active or a dominant negative, IRF3a, form of IRF3 [33].
Because it appears that by converting to a U2 intron, human
IRF3 intron 5 lost its rate-limiting function, it is intriguing to
contemplate that this led to emergence of an alternative
splicing control mechanism for human IRF3.
Our choice of mouse strains for genetic analysis of
susceptibility to L. monocytogenes infection was based on the
existence of the ByJ-based CXB RI mapping panel. The
C57BL/6By substrain has been used to generate at least seven
of the 13 CXB RI strains, but none of the CXB strains appear
to have a defect in induction of Ifnb1. To resolve this
discrepancy, we sequenced Irf3 intron 5 in all C57BL/6By-
derived CXB strains. None of the sequenced Irf3 introns
contained the mutation found in the C57BL/6ByJ strain
(unpublished data). Therefore, it appears that the A to T
mutation rose in the C57BL/6ByJ background only recently,
after the generation of the CXB RI strains. It is possible that
the return of D. W. Bailey’s substrains to the Production
Department of Jackson Laboratories in 1974 could have
created a bottleneck that ﬁxed the mutation in the current
C57BL/6ByJ population.
Splicing of mRNA is a critical step in protein expression,
and in humans, genetic polymorphisms that produce aber-
rant or alternate splicing products have been associated with
a wide range of diseases [34]. We used genetic analysis of the
mouse model system to provide deﬁnitive evidence of the
important role of splicing in control of infection. We found
that a mouse substrain-speciﬁc defect in induction of Ifnb1 is
due to a single nucleotide polymorphism in intron 5 of Irf3.
Our analysis of this polymorphism revealed that splicing is a
critical step in the control of Irf3 expression and, as a result,
in the course and outcome of L. monocytogenes infection. While
intron 5 of murine Irf3 has features of both U2 and U12
introns, we provide evidence that its splicing is dependent on
the U12 spliceosome. Therefore, it appears that in rodents
the U12 spliceosome can use U2 splice sites. This suggests that
the spectrum of U12-type introns present in mammalian
genomes could be wider than previously thought. Finally, our
comparison of rodent and primate Irf3 genomic sequences
also revealed the intriguing possibility that we have identiﬁed
an intermediate step in the process of conversion from a
U12- to U2-type intron.
Materials and Methods
Animals. Six-to-twelve-week-old animals were used in all experi-
ments. BALB/cByJ, C57BL/6J, and C57BL/6ByJ mice were obtained
from Jackson Laboratories (http://www.jax.org/). B/ByJ.C N2 mice were
created by backcrossing B/ByJ.C F1 males to C57BL/6ByJ females. All
mouse strains were bred and maintained under speciﬁc pathogen-
free conditions in the animal facilities at the University of
Massachussetts Medical School. All experiments involving live
animals were carried out in accordance with the guidelines set forth
by the University of Massachussetts Medical School Department of
Animal Medicine and the Institute Animal Care and Use Committee.
In vivo infections. Pre-titered TSB-glycerol stocks of L. moncytogenes
strain 10403S were stored at 80 8C. Prior to infection, 1-ml bacterial
aliquots were recovered for 1 h at 37 8C in 9 ml of TSB (BD
Biosciences, ttp://www.bdbiosciences.com/), washed, and resuspended
to the desired cfu in PBS. Mice were injected with a deﬁned dose of L.
monocytogenes strain 10403S in 0.4 ml of PBS. At deﬁned time points,
infected animals were killed by CO2 asphyxiation. Livers and spleens
of infected animals were aseptically harvested, weighed, and
homogenized in 0.02% Triton X-100. Aliquots of serial 5-fold
dilutions in sterile water were plated in duplicate on TSB agar (BD
Biosciences) plates containing 10 lg/ml streptomycin. After overnight
incubation, the number of bacteria per milligram of tissue was
determined by counting colonies at the appropriate dilution.
Generation of bone marrow macrophages. BMMs were generated
by differentiating bone marrow calls in a complete BM medium
(DMEM, 10% heat-inactivated FCS (Invitrogen, http://www.invitrogen.
com/), 100 U/ml penicillin (Invitrogen), 100 lg/ml streptomycin
(Invitrogen), and 10% L929 ﬁbroblast-conditioned medium as a
source of M-CSF) for 6 d in 10-cm Petri dishes (VWR, http://www.vwr.
com/).
Cell lines. Fibroblast-like YF5 and macrophage-like YM14 cell lines
were generated by immortalization of C57BL/6ByJ bone marrow cells
as previously described [35,36]. Clones were selected based on
morphology.
Ex vivo experiments. Differentiated BMMs were detached from the
Petri plates by incubation in cold PBS, washed, resuspended in BM
medium without antibiotics and used to seed multiwell dishes at 1 3
10
5 cells/cm
2. Following overnight incubation the medium was
replaced with DMEM containing the agent used to stimulate BMM.
For L. monocytogenes, after 1 h the medium was replaced with BM
medium containing 10 lg/ml gentamicin (Fisher) to remove extrac-
ellular bacteria. Lipopolysaccharide (Sigma) was added at 1 lg/ml,
poly I:poly C (Sigma) at 25 lg/ml and Sendai Virus (generous gift of
Kate Fitzgerald, University of Massachussetts) at 200 U/ml. At deﬁned
Figure 7. Levels of Ifnb1 mRNA Expression in C57BL/6ByJ BMMs
following Transfection of Irf3 mRNAs That Are Fully Spliced, Contain
Intron 5, or Deleted for IRF Domain (DXma)
Ifnb1 mRNA expression was measured by RT RT-PCR either 19 h (T19)
following transfection or after 15 h transfection plus 4 h infection with L.
monocytogenes (T15 þ 4h LM). A representative of three independent
experiments is shown.
doi:10.1371/journal.pgen.0030152.g007
PLoS Genetics | www.plosgenetics.org September 2007 | Volume 3 | Issue 9 | e152 1595
Irf3 Splicing Controls Resistance to Infectiontimepoins BMMs were lysed in TRIzol (Invitrogen) and RNA was
isolated according to manufacturer’s protocol.
BMM cell death assay. 5310
4 BMMs were seeded in 96-well tissue
culture plate and following overnight incubation the cells were
infected with a deﬁned multiplicity of infection (MOI) of L.
monocytogenes. After 1 h incubation, the cell culture medium was
replaced with medium containing 10 lg/ml of gentamicin (MP
Biomedicals, http://www.mpbio.com/). At deﬁned time points the
supernatants were collected and the remaining cells were lysed for 20
min at room temperature in 50 ll/well of complete medium plus 1ll
of cell lysis solution from CytoTox-ONE Homogeneous Membrane
Integrity Assay kit (Promega, http://www.promega.com/). Lactose
dehydrogenase (LDH) assay for supernatants and cell lysates was
performed according to the manufacturer’s protocol. Fluorescence
was recorded at 560/590 nm using a Synergy HT microplate reader
(Bio-Tek, http://www.biotek.com/). The relative concentration of LDH
in supernatants was calculated by the equation: 100% 3 (LDHsup/
(LDHsupþLDHcell)).
Real time PCR. Relative mRNA levels were quantiﬁed by real time
RT-PCR on an ABI 7300 instrument (http://www.appliedbiosystems.
com/) utilizing SYBR Green chemistry (ABI SYBR master mix þ RT
reagents). Generally, 50 ng of total RNA was used in 20 ml one-step
reactions that incorporated a 30-min reverse transcription step prior
to cycling. Primers used to detect speciﬁc mRNAs are described in
Table S1. Ribosomal protein S17 (Rps17) and actin mRNA were used
as a loading controls. To quantify the relative amounts of mRNA in
each experiment, 2-fold dilutions were used to create calibration
curves. Each experiment included at least two biological and three
experimental replicates.
Genetic mapping. BMMs from 46 B/ByJ(C.B/ByJ) N2 mice were
infected in duplicate with L. monocytogenes strain 10403S at MOI ¼ 5.
Four hours following infection, total RNA was isolated and used for
real time RT-PCR analysis of Ifnb1 mRNA induction. Ifnb1 Ct values
from duplicate samples were adjusted for variation in total RNA
concentration using Rps17 Ct values, transformed by subtracting the
average C57BL/6ByJ parental value, and used directly as trait values
for mapping using MapManger software. Under ideal conditions,
such transformed Ct values can be viewed as log2 of the fold
difference in Ifnb1 expression compared to the C57BL/6ByJ parent. A
genetic map was constructed using 56 microsatelite markers [16].
Experimental p-value for linkage was evaluated using a built-in
permutation test and was found to be less than 10
 4.
IRF3 immunoblotting. BMMs were infected with L. monocytogenes
(MOI ¼ 5) or Sendai Virus (600 HU) for 4 h. Cells were lysed in the
presence of protease inhibitors (Roche, http://www.roche.com/) and
following centrifugation, supernatant aliquots containing 20 lgo f
protein were loaded per lane of a native polyacrylamide gel. IRF3 was
detected by immunoblotting with an anti-IRF3 antibody (Invitrogen).
For total IRF3 protein analysis, lysates were obtained from infected
and uninfected BMMs treated with either 10 lM MG-132 proteasome
inhibitor or DMSO vehicle. Three micrograms of total protein were
separated on denaturing SDS polyacrylamide gel and immumoblot-
ted with anti IRF-3 antibobody (Invitorgen).
RNA transfection. The cDNAs of fully spliced Irf3, Irf3 lacking
internal XmaI fragment, and strain-speciﬁc Irf3 species retaining
intron 5 were ampliﬁed with IRF3Fþ1 and IRF3dT32SspIR oligonu-
cleotides (Table S1). IRF3dT32SspIR was designed to introduce
poly(A)32 and a unique SspI site at the 39 end of Irf3 coding sequences.
Ampliﬁed Irf3 fragments were cloned in front of T7 promoter of
pCR2.1 vector (Invitrogen). To generate Irf3 mRNAs, 1 lgo f
respective SspI linearized plasmids was used as templates in in vitro
transcription reactions (Maxiscript T7; Ambion, http://www.ambion.
com/). One microgram of DNAse treated, reprecipitated RNA was
used for nucleofection of 1 to 1.5 3 10
6 BMMs in 100 ll of complete
mouse macrophage nucleofector solution (82 ll mouse macrophage
nucleofector solution plus 18 ll supplement) from Mouse Macro-
phage Nucleofector kit (Amaxa Biosystems, http://www.amaxa.com/).
Following electroporation using a Nucleofector II electroporation
device (Amaxa) with program Y-001, cells were split into two wells of
a 24-well culture plate, each containing 1 ml of RPMI/10% FBS/10%
LCCM medium.
Flow cytometry. Splenocytes were isolated by disrupting aseptically
harvested spleens in RPMI 10% FCS using a 70-lm pore size mesh cell
strainer (BD Biosciences) to obtain single-cell suspensions. Red blood
cells were lysed in ACK buffer (Sigma-Aldrich, http://www.
sigmaaldrich.com/). Splenocytes were resuspended to obtain 2 3 10
7
cells/ml in HBSS supplemented with 0.5% and 0.1% NaN3. Each
sample containing 1 3 10
6 cells was blocked with FcR-blocking
antibody (CD16/CD32) and stained with respective directly conju-
gated antibodies and their isotype controls. Stained cells were ﬁxed in
1% paraformaldehyde (Sigma-Aldrich) for 24 h prior to analysis
using a FACScan ﬂow cytometer (BD Biosciences).
Splicing assays. C57BL/6J and C57BL/6ByJ minigene constructs
were generated by cloning Irf3 intron 5 ﬂanked by 250 bp of exonic
sequences into the vector pcDNA3 (Invitrogen), to create pINT5J and
pINT5ByJ, respectively. For ex vivo splicing assays, the C57BL/6ByJ-
derived ﬁbroblast-like cell line Y5 was transfected with either pINT5J
or pINT5ByJ, and splicing was monitored 12 h later by real time RT-
PCR using primers speciﬁc to the transcribed vector sequence
(pCDNA3F3) and either intron 5 (IRF3IntR) or the exon 5–6 junction
(IRF3Ex5/6R5,). For in vitro splicing assays, minigene Irf3 pre-mRNA
templates were PCR-ampliﬁed from pINT5J and pINT5ByJ using a
T7-containing primer, puriﬁed, and transcribed in vitro using T7
polymerase in the presence of [alpha-
32P]UTP. In vitro splicing
reactions were performed essentially as described previously [37],
except that 30% HeLa nuclear extract was used. Spliced products
were resolved on 12% denaturing polyacrylamide gels (19:1) in 8 M
urea in Tris-Borate-EDTA buffer, and visualized using a Fujiﬁlm FLA-
500 phosphorimager (http://www.fujiﬁlm.com/). U2 and U12 snRNAs
were inactivated by RNase H–directed cleavage as described
previously [38] using DNA oligonucleotides complementary to
nucleotides 27–49 of the U2 snRNA or to nucleotides 11–28 of the
U12 snRNA.
Genes. All genes mentioned in the text and their corresponding
National Center for Biotechnology Information (NCBI) GeneID
(http://www.ncbi.nlm.nih.gov/sites/gquery) and Ensembl (http://www.
ensembl.org/) identiﬁers are described in Table S2.
Supporting Information
Figure S1. Levels of Ifnb1 mRNA in Tissues of Infected Animals
Ifnb1 mRNA was not detectable in livers and spleens of animals
infected with 1310
5 L. monocytogenes until the 24-h time point. Forty-
eight hours after infection, spleens of C57BL/6J animals had 6-fold
higher levels of Ifnb1 mRNA than C57BL/6ByJ animals.
Found at doi:10.1371/journal.pgen.0030152.sg001 (238 KB EPS).
Figure S2. Survival of C57BL/6J and C57BL/6ByJ Mice following
Intravenous Infection with 1 3 10
5 cfu L. monocytogenes Strain 10403S
The majority of C57BL/6ByJ mice survive for more then 10 d
following infection.
Found at doi:10.1371/journal.pgen.0030152.sg002 (72 KB EPS).
Figure S3. MapManager QTX Chromosome 7 Interval Mapping
Results
Likelihood ratio statistic scores represent thresholds of suggestive,
signiﬁcant, and highly signiﬁcant linkages, respectively.
Found at doi:10.1371/journal.pgen.0030152.sg003 (206 KB EPS).
Figure S4. High Levels of Spliced Irf3 mRNA Induce Death of BMMs
Survival of C57BL/6J Irf3
 /  BMMs following 24-h transfection of in
vitro transcribed Irf3 mRNAs was monitored by the release of the
cytosolic enzyme LDH into the supernatant.
Found at doi:10.1371/journal.pgen.0030152.sg004 (240 KB EPS).
Table S1. Sequences of Primers Used in This Study
Found at doi:10.1371/journal.pgen.0030152.st001 (19 KB PDF).
Table S2. NCBI GeneID and Ensembl Identiﬁers for Genes Mentioned
in the Text
Found at doi:10.1371/journal.pgen.0030152.st002 (27 KB PDF).
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